Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashina, M.
Right arrow Articles by Olesen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashina, M.
Right arrow Articles by Olesen, J.
Neurology 2000;55:1335-1340
© 2000 American Academy of Neurology


Articles

Plasma levels of calcitonin gene-related peptide in chronic tension-type headache

M. Ashina, MD, PhD, L. Bendtsen, MD, PhD, R. Jensen, MD, PhD, S. Schifter, MD, PhD, I. Jansen–Olesen, PhD and J. Olesen, MD, PhD

From the Departments of Neurology (Drs. Ashina, Bendtsen, Jensen, and Olesen) and Clinical Physiology and Nuclear Medicine (Dr. Schifter), Glostrup Hospital, University of Copenhagen; and Department of Biological Sciences, Royal School of Pharmacy (Dr. Jansen–Olesen), Copenhagen, Denmark.

Address correspondence and reprint requests to Dr. M. Ashina, Department of Neurology, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Copenhagen, Denmark; e-mail: ashina{at}dadlnet.dk

BACKGROUND: Calcitonin gene-related peptide (CGRP) is involved in the pathophysiology of migraine and cluster headache. Whether CGRP has any role in chronic tension-type headache is unknown.

OBJECTIVES: To compare interictal plasma levels of CGRP between patients with chronic tension-type headache and healthy control subjects, to investigate plasma CGRP in relation to headache state, and to compare plasma CGRP between the peripheral and the cranial circulation.

METHODS: Blood from the antecubital vein was drawn from 30 patients with chronic tension-type headache and 34 healthy control subjects. In addition, blood samples from the consecutive first 15 patients and from the consecutive first 20 healthy control subjects were also collected from the external jugular vein.

RESULTS: CGRP levels measured in the peripheral circulation in patients on days without headache, 63 ± 5 pmol/L, tended to be higher than CGRP levels in control subjects, 53 ± 3 pmol/L (p = 0.06). In patients, no differences were found between CGRP levels assessed ictally and interictally in either the cranial (p = 0.91) or the peripheral (p = 0.62) circulation. Plasma CGRP level was higher in the external jugular vein than in the antecubital vein on days without headache (p = 0.03) but not on days with headache (p = 0.82). In control subjects, CGRP levels in the cranial circulation did not differ from CGRP levels in the peripheral circulation (p = 0.92). Exploratory analyses showed that 8 patients whose usual headache quality was throbbing had a higher interictal plasma CGRP level than control subjects (p = 0.002), whereas plasma CGRP level was normal in 22 patients with pressing headaches (p = 0.36).

CONCLUSIONS: Plasma levels of CGRP are normal in patients with chronic tension-type headache and are unrelated to headache state. Interictal plasma CGRP was increased in patients with a pulsating pain quality. Because the authors have previously shown a similar increase of interictal CGRP levels in migraine, this study suggests that headaches with symptoms that fulfill International Headache Society criteria for tension-type headache may be pathophysiologically related to migraine, if the headache has a pulsating quality.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. J. M. Fischer, S. Koulchitsky, and K. Messlinger
The Nonpeptide Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Lowers the Activity of Neurons with Meningeal Input in the Rat Spinal Trigeminal Nucleus
J. Neurosci., June 22, 2005; 25(25): 5877 - 5883.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. D. Brain and A. D. Grant
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Physiol Rev, July 1, 2004; 84(3): 903 - 934.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. J. Goadsby, K. L. Hoskin, R. J. Storer, L. Edvinsson, and H. E. Connor
Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission
Brain, June 1, 2002; 125(6): 1392 - 1401.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P. J Goadsby and C. Boes
CHRONIC DAILY HEADACHE
J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(90002): ii2 - 5.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.